Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Protein Expression and Purification|January 13, 2006
Expression of compstatin in Escherichia coli: incorporation of unnatural amino acids enhances its activityMadan Katragadda, John D LambrisThe Journal of Biological Chemistry|October 19, 2004
Thermodynamic studies on the interaction of the third complement component and its inhibitor, compstatinMadan Katragadda, Dimitrios Morikis, John D LambrisJournal of Medicinal Chemistry|July 21, 2006
Hydrophobic effect and hydrogen bonds account for the improved activity of a complement inhibitor, compstatinMadan Katragadda, Paola Magotti, Georgia Sfyroera, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2005
Electrostatic modeling predicts the activities of orthopoxvirus complement control proteinsGeorgia Sfyroera, Madan Katragadda, Dimitrios Morikis, et al.Experimental Eye Research|September 6, 2003
A soluble peripherin/Rds C-terminal polypeptide promotes membrane fusion and changes conformation upon membrane associationKathleen Boesze-Battaglia, Andrew F X Goldberg, Janice Dispoto, et al.Journal of Medicinal Chemistry|January 7, 2005
Design and NMR characterization of active analogues of compstatin containing non-natural amino acidsBuddhadeb Mallik, Madan Katragadda, Lynn A Spruce, et al.Mabs|October 10, 2017
Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokineticsNicole M Piche-Nicholas, Lindsay B Avery, Amy C King, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 1, 2010
Anti-PDGF-B monoclonal antibody reduces liver fibrosis developmentShinji Ogawa, Takashi Ochi, Hideaki Shimada, et al.Journal for Immunotherapy of Cancer|October 28, 2025
Combination of a novel TCR Vβ chain-directed selective T cell activator with standard of care therapy for head and neck cancer improves antitumor responses and promotes regression of checkpoint-refractory tumor modelsFrancesca Rosato, Ginette Santiago-Sanchez, Kellsye P Fabian, et al.Frontiers in Immunology|June 19, 2026
Docetaxel enhances Vβ-directed T-cell activation and antitumor immunity mediated by a bifunctional TCR agonist in breast and prostate cancer modelsJonelle K Lee, Kellsye P Fabian, Ginette S Santiago-Sanchez, et al.Pageof 2